This contract expires in 69 days (Aug 19, 2026).

Browse related active opportunities

COST PLUS FIXED FEENO SET ASIDE USED.

CRESTONE, INC. - TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.

PIID: 75N93020C00020Solicitation ID: HHS-NIH-NIAID-BAA2019-1
Signed Date: Jan 7, 2026Effective Date: Jul 1, 2020End Date: Closes in 69 days
Award $
$20.5M
Vendor
CRESTONE, INC.
NAICS
541715
Signed Date
Jan 7, 2026

Key Details

Dollars Obligated
$20.5M
Base & All Options
$2.0M
Awarding Sub-Agency
National Institutes of Health
Product Service Code
AN12 - HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Extent Competed
FULL AND OPEN COMPETITION
Number of Offers
12
Place of Performance
BOULDER, CO, 803013203, CD-CO-02

Description

TO ADVANCE A PROMISING, SMALL-MOLECULE COMPOUND CRS0540 TO IND FILING AND THROUGH PHASE I CLINICAL STUDIES.

Context & Analysis

On Jan 7, 2026, Department of Health and Human Services obligated $20,477,990 to CRESTONE, INC. for to advance a promising, small-molecule compound crs0540 to ind filing and through phase i clinical studies.. The award is classified under NAICS 541715 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) and issued as a cost plus fixed fee contract. Competition extent: full and open competition with 12 offers received. The procurement used a NO SET ASIDE USED. set-aside. Performance is located in BOULDER, CO. The contract is scheduled through Aug 19, 2026 — approximately 2 months remaining. This award is one of several similar procurements from Department of Health and Human Services under NAICS 541715 — related awards are listed below.

Contractor Information

Contractor: CRESTONE, INC.
UEI: EDSLAP2J1BL8
CAGE Code: 5RDJ6
Location: BOULDER, CO
View Full Record on USASpending.gov

Stay Updated

Get notified about new opportunities matching your interests.

Related